Suppr超能文献

国际辅助生殖技术监测委员会世界报告:2008年、2009年及2010年辅助生殖技术情况

International Committee for Monitoring Assisted Reproductive Technologies world report: Assisted Reproductive Technology 2008, 2009 and 2010.

作者信息

Dyer S, Chambers G M, de Mouzon J, Nygren K G, Zegers-Hochschild F, Mansour R, Ishihara O, Banker M, Adamson G D

机构信息

Department of Obstetrics & Gynaecology, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa

National Perinatal Epidemiology and Statistics Unit, University of New South Wales, Sydney, Australia.

出版信息

Hum Reprod. 2016 Jul;31(7):1588-609. doi: 10.1093/humrep/dew082. Epub 2016 May 20.

Abstract

STUDY QUESTION

What were utilization, outcomes and practices in assisted reproductive technology (ART) globally in 2008, 2009 and 2010?

SUMMARY ANSWER

Global utilization and effectiveness remained relatively constant despite marked variations among countries, while the rate of single and frozen embryo transfers (FETs) increased with a concomitant slight reduction in multiple birth rates.

WHAT IS KNOWN ALREADY

ART is widely practised in all regions of the world. Monitoring utilization, an approximation of availability and access, as well as effectiveness and safety is an important component of universal access to reproductive health.

STUDY DESIGN, SIZE, DURATION: This is a retrospective, cross-sectional survey on utilization, effectiveness and safety of ART procedures performed globally from 2008 to 2010.

PARTICIPANTS, SETTING, METHODS: Between 58 and 61 countries submitted data from a total of nearly 2500 ART clinics each year. Aggregate country data were processed and analyzed based on forms and methods developed by the International Committee for Monitoring Assisted Reproductive Technologies (ICMART). Results are presented at country, regional and global level.

MAIN RESULTS AND THE ROLE OF CHANCE

For the years 2008, 2009 and 2010, >4 461 309 ART cycles were initiated, resulting in an estimated 1 144 858 babies born. The number of aspirations increased by 6.4% between 2008 and 2010, while FET cycles increased by 27.6%. Globally, ART utilization remained relatively constant at 436 cycles/million in 2008 and 474 cycles/million population in 2010, but with a wide country range of 8-4775 cycles/million population. ICSI remained constant at around 66% of non-donor aspiration cycles. The IVF/ICSI combined delivery rate (DR) per fresh aspiration was 19.8% in 2008; 19.7% in 2009 and 20.0% in 2010, with corresponding DRs for FET of 18.8, 19.7 and 20.7%. In fresh non-donor cycles, single embryo transfer increased from 25.7% in 2008 to 30.0% in 2010, while the average number of embryos transferred fell from 2.1 to 1.9, again with wide regional variation. The rates of twin deliveries following fresh non-donor transfers were, in 2008, 2009 and 2010, 21.8, 20.5 and 20.4%, respectively, with a corresponding triplet rate of 1.3, 1.0 and 1.1%. Fresh IVF and ICSI carried a perinatal mortality rate per 1000 births of 22.8 (2008), 19.2 (2009) and 21.0 (2010), compared with 15.1, 12.8 and 14.6/1000 births following FET in the same periods of observation. The proportion of women aged 40 years or older undergoing non-donor ART increased from 20.8 to 23.2% from 2008 to 2010.

LIMITATIONS, REASON FOR CAUTION: The data presented are reliant on the quality and completeness of data submitted by individual countries. This report covers approximately two-thirds of the world ART activity.

WIDER IMPLICATIONS OF FINDINGS

The ICMART World Reports provide the most comprehensive global statistical census and review of ART utilization, effectiveness, safety and quality. While ART treatment continues to increase globally, the wide disparities in access to treatment and embryo transfer practices warrant attention by clinicians and policy makers.

STUDY FUNDING/COMPETING INTERESTS: The authors declare no conflict of interest and no specific support from any organizations in relation to this manuscript. ICMART acknowledges financial support from the following organizations: American Society for Reproductive Medicine; European Society for Human Reproduction and Embryology; Fertility Society of Australia; Japan Society for Reproductive Medicine; Japan Society of Fertilization and Implantation; Red Latinoamericana de Reproduccion Asistida; Society for Assisted Reproductive Technology; Government of Canada (Research grant), Ferring Pharmaceuticals (Grant unrelated to World Reports).

TRIAL REGISTRATION

not applicable.

摘要

研究问题

2008年、2009年和2010年全球辅助生殖技术(ART)的使用情况、结局及操作是怎样的?

简要回答

尽管各国之间存在显著差异,但全球的使用情况和有效性保持相对稳定,同时单胚胎移植和冻融胚胎移植(FET)的比例增加,多胎出生率随之略有下降。

已知信息

ART在世界所有地区都广泛应用。监测使用情况(可及性和可获得性的一种近似指标)以及有效性和安全性是普及生殖健康的重要组成部分。

研究设计、规模、持续时间:这是一项关于2008年至2010年全球ART程序使用情况、有效性和安全性的回顾性横断面调查。

参与者、研究环境、方法:每年有58至61个国家提交来自总共近2500家ART诊所的数据。根据国际辅助生殖技术监测委员会(ICMART)制定的表格和方法对各国汇总数据进行处理和分析。结果在国家、区域和全球层面呈现。

主要结果及机遇的作用

在2008年、2009年和2010年,启动了超过4461309个ART周期,估计有1144858名婴儿出生。2008年至2010年间,取卵次数增加了6.4%,而FET周期增加了27.6%。全球范围内,ART使用率在2008年为每百万人口436个周期,2010年为每百万人口474个周期,相对稳定,但各国差异较大,范围为每百万人口8 - 4775个周期。卵胞浆内单精子注射(ICSI)在非供体取卵周期中保持在约66%。2008年新鲜取卵的体外受精(IVF)/ICSI联合分娩率(DR)为19.8%;2009年为19.7%,2010年为20.0%,FET的相应DR分别为18.8%、19.7%和20.7%。在新鲜非供体周期中,单胚胎移植从2008年的25.7%增加到2010年的30.0%,而平均移植胚胎数从2.1个降至1.9个,同样存在较大的区域差异。2008年、2009年和2010年新鲜非供体移植后的双胎分娩率分别为21.8%、20.5%和20.4%,相应的三胎率为1.3%、1.0%和1.1%。2008年、2009年和2010年新鲜IVF和ICSI每1000例出生的围产儿死亡率分别为22.8、19.2和21.0,而同期FET后的围产儿死亡率为每1000例出生15.1、12.8和14.6。2008年至2010年,接受非供体ART的40岁及以上女性比例从20.8%增加到23.2%。

局限性、谨慎理由:所呈现的数据依赖于各国提交数据的质量和完整性。本报告涵盖了全球约三分之二的ART活动。

研究结果的更广泛影响

ICMART世界报告提供了关于ART使用情况、有效性、安全性和质量最全面的全球统计普查及综述。虽然全球ART治疗持续增加,但治疗可及性和胚胎移植操作的巨大差异值得临床医生和政策制定者关注。

研究资金/利益冲突:作者声明无利益冲突,且本稿件未得到任何组织的特定支持。ICMART感谢以下组织的资金支持:美国生殖医学学会;欧洲人类生殖与胚胎学会;澳大利亚生育学会;日本生殖医学学会;日本受精与着床学会;拉丁美洲辅助生殖网络;辅助生殖技术协会;加拿大政府(研究资助),辉凌制药(与世界报告无关的资助)。

试验注册

不适用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验